SpyGlass Pharma, Inc. (SGP) stock
SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$29.68−1.75 (-5.58%)
Close on Nov 18, 2026Market cap $992.74MP/E –Yield –
SpyGlass Pharma free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -$33.49M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$33.49M | – |
| FY2024 | Dec 31, 2024 | -$24.02M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$16.77M | – |
| Q1 FY2026 | Mar 31, 2026 | -$14.22M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.38M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.37M | – |
See a number that looks wrong?